In the last trading session, 4.64 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.07. Most recently the company’s share price was $0.07, and it changed around $0.0 or -2.74% from the last close, which brings the market valuation of the company to $2.12M. PTPI currently trades at a discount to its 52-week high of $1.59, offering almost -2171.43% off that amount. The share price’s 52-week low was $0.06, which indicates that the current value has risen by an impressive 14.29% since then. We note from Petros Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 10.36 million shares, with the 3-month average coming to 7.19 million.

Petros Pharmaceuticals Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended PTPI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Instantly PTPI has showed a red trend with a performance of -2.74% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.0798 on recent trading dayincreased the stock’s daily price by 12.28%. The company’s shares are currently down -81.98% year-to-date, but still down -8.86% over the last five days. On the other hand, Petros Pharmaceuticals Inc (NASDAQ:PTPI) is -43.20% down in the 30-day period. We can see from the shorts that 0.35 million shares have been sold at a short interest cover period of 0.03 day(s).

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 5.75% of Petros Pharmaceuticals Inc shares, and 8.68% of them are in the hands of institutional investors. The stock currently has a share float of 9.21%.